Don't F*** with the Density of Ice

Continued biomedical progress relies on an unappreciated foundation. Market-based pricing of new medicines for a patent-intended period of time combined with proper insurance with low out-of-pocket costs provide the necessary incentives for innovation and ensure broad access to new treatments.

Previous
Previous

The Impact of the Inflation Reduction Act on Early-Stage Biomedical Investment Decisions

Next
Next

Value in Health: It’s time to reconsider the three percent discount rate.